REDUCTION OF ANTERIOR UVEITIS FLARES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS FOLLOWING ONE YEAR OF TREATMENT WITH CERTOLIZUMAB PEGOL: 48-WEEK INTERIM RESULTS FROM A 96-WEEK OPEN-LABEL STUDY

被引：0

作者：

Van der Horst-Bruinsma, I. ^{[1
]}

Van Bentum, R. ^{[1
]}

Verbraak, F. ^{[1
]}

Rath, T. ^{[2
]}

Rosenbaum, J. ^{[3
,4
]}

Misterska-Skora, M. ^{[5
]}

Hoepken, B. ^{[6
]}

Irvin-Sellers, O. ^{[7
]}

Vanlunen, B. ^{[8
]}

Bauer, L. ^{[6
]}

Rudwaleit, M. ^{[9
,10
]}

机构：

[1] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] St Franziskus Hosp, Munster, Germany

[3] Devers Eye Inst, Portland, OR USA

[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[5] Wroclaw Med Univ, Wroclaw, Poland

[6] UCB Pharma, Monheim, Germany

[7] UCB Pharma, Slough, Berks, England

[8] UCB Pharma, Raleigh, NC USA

[9] Klinikum Bielefeld & Charite, Berlin, Germany

[10] Univ Ghent, Ghent, Belgium

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.3747

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0379

引用

页码：419 / 419

页数：1

共 50 条

[1] Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study
van der Horst-Bruinsma, Irene
van Bentum, Rianne
Verbraak, Frank D.
Rath, Thomas
Rosenbaum, James T.
Misterska-Skora, Maria
Hoepken, Bengt
Irvin-Sellers, Oscar
VanLunen, Brenda
Bauer, Lars
Rudwaleit, Martin
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[2] Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis During Certolizumab Pegol Treatment: 96-Week Results from the C-VIEW Study
van der Horst-Bruinsma, Irene
van Bentum, Rianne
Verbraak, Frank
Rath, Thomas
Rosenbaum, James
Hoepken, Bengt
Irvin-Sellers, Oscar
Kumke, Thomas
Bauer, Lars
Rudwaleit, Martin
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[3] Reduction of Anterior Uveitis Flares in Patients With Axial Spondyloarthritis During Certolizumab Pegol Treatment: 96-Week Results from the C-VIEW Study
van der Horst-Bruinsma, Irene
van Bentum, Rianne
Verbraak, Frank
Rath, Thomas
Hoepken, Bengt
Irvin-Sellers, Oscar
Kumke, Thomas
Bauer, Lars
Haroon, Nigil
Rudwaleit, Martin
[J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1119 - 1119
[4] The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW
Van der Horst-Bruinsma, Irene
van Bentum, Rianne
Verbraak, Frank D.
Rath, Thomas
Rosenbaum, James T.
Misterska-Skora, Maria
Hoepken, Bengt
Irvin-Sellers, Oscar
VanLunen, Brenda
Bauer, Lars
Rudwaleit, Martin
[J]. RMD OPEN, 2020, 6 (01):
[5] REDUCTION OF ANTERIOR UVEITIS FLARES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DURING CERTOLIZUMAB PEGOL TREAT MENT: 96-WEEK RESULTS FROM THE C-VIEW STUDY
Van der Horst-Bruinsma, I.
Van Bentum, R.
Verbraak, F.
Rath, T.
Hoepken, B.
Irvin-Sellers, O.
Kumke, T.
Bauer, L.
Rudwaleit, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 705 - 706
[6] EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL: RESULTS FROM THE 48-WEEK RUN-IN PART OF A 96-WEEK STUDY (NCT02505542)
Landewe, Robert
van der Heijde, Desiree
Dougados, Maxime
Baraliakos, Xenofon
Van den Bosch, Filip
Gaffney, Karl
Hoepken, Bengt
Thomas, Karen
Gensler, Lianne S.
[J]. RHEUMATOLOGY, 2019, 58
[7] Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE
Landewe, Robert
van der Heijde, Desiree
Dougados, Maxime
Baraliakos, Xenofon
van den Bosch, Filip
Gaffney, Karl
Bauer, Lars
Hoepken, Bengt
de Peyrecave, Natasha
Thomas, Karen
Gensler, Lianne S.
[J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 581 - 599
[8] Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE
Robert Landewé
Désirée van der Heijde
Maxime Dougados
Xenofon Baraliakos
Filip Van den Bosch
Karl Gaffney
Lars Bauer
Bengt Hoepken
Natasha de Peyrecave
Karen Thomas
Lianne S. Gensler
[J]. Rheumatology and Therapy, 2020, 7 : 581 - 599
[9] Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study
van der Heijde, Desiree
Braun, Juergen
Rudwaleit, Martin
Purcaru, Oana
Kavanaugh, Arthur F.
[J]. RMD OPEN, 2018, 4 (01):
[10] Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study
van der Horst-Bruinsma, Irene E.
van Bentum, Rianne E.
Verbraak, Frank D.
Deodhar, Atul
Rath, Thomas
Hoepken, Bengt
Irvin-Sellers, Oscar
Thomas, Karen
Bauer, Lars
Rudwaleit, Martin
[J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13

← 1 2 3 4 5 →